GPN vs INBX · P/E 24, rev $6.29B vs rev $1.3M
Global Payments Inc (GPN) versus Inhibrx Biosciences, Inc. (INBX) — a side-by-side from cached financials, not a winner call.
Global Payments Inc (GPN) is a specialty business services company listed on US.
Inhibrx Biosciences, Inc. (INBX) is a biotechnology company listed on US.
Latest reported GPN revenue for 2026-06-30 was $6.29B. Net income was -$1.79B. GPN currently screens at market cap $18.14B and trailing P/E 24.4.
Latest reported INBX revenue for 2025-12-31 was $1.3M. Net income was -$140.1M. Revenue was up 550.0% from 2024-12-31 to 2025-12-31. INBX currently screens at market cap $1.28B.
GPN currently screens at market cap $18.14B and trailing P/E 24.4. INBX currently screens at market cap $1.28B.
Not investment advice. Open the GPN and INBX stock pages for the full models.
Not investment advice.